TITLE

Generex Raising $20.7M Privately For Oral-lyn Insulin Spray Trials

AUTHOR(S)
Boggs, Jennifer
PUB. DATE
April 2008
SOURCE
BioWorld Today;4/3/2008, Vol. 19 Issue 65, p3
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
This article reports on the money being raised by Generex Biotechnology Corp. to support the late-stage trials of Oral-lyn, an insulin spray product for Type I and Type II diabetes patients. Eight percent of convertible notes and warrants will be issued by Generex Biotechnology to existing institutional investors. Shareholder approval will be sought by Generex Biotechnology during its meeting on May 27, 2008.
ACCESSION #
31536206

 

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics